搜索临床试验以:丙酸氟替卡松 250mcg / 沙美特罗 50mcg
总计868个结果
-
ViiV HealthcareGlaxoSmithKline; Shionogi完全的
-
King's College Hospital NHS TrustMerck Sharp & Dohme LLC; Hepatitis C Trust终止
-
GlaxoSmithKline完全的
-
GlaxoSmithKline完全的哮喘美国, 俄罗斯联邦, 加拿大, 德国, 秘鲁, 澳大利亚, 墨西哥, 智利, 哥斯达黎加, 西班牙, 波兰, 立陶宛, 拉脱维亚
-
NYU Langone HealthNational Institute for Occupational Safety and Health (NIOSH/CDC)完全的
-
GlaxoSmithKline完全的
-
National Cancer Institute (NCI)完全的男性乳腺癌 | IV 期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌美国
-
GlaxoSmithKline完全的
-
Massachusetts General HospitalMerck Sharp & Dohme LLC完全的
-
Chinese PLA General HospitalTianjin TongRenTang Group Co., Ltd.未知
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Marrow... 和其他合作者完全的
-
GlaxoSmithKline撤销
-
Chengdu Zenitar Biomedical Technology Co., Ltd招聘中
-
Cingulate TherapeuticsRho, Inc.完全的
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完全的
-
Insel Gruppe AG, University Hospital BernUniversity of Bern尚未招聘
-
Gulhane School of Medicine完全的
-
Research in Real-Life LtdTeva Branded Pharmaceutical Products R&D, Inc.完全的
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São Paulo招聘中
-
Seoul National University Bundang HospitalLG Life Sciences未知
-
Henan Cancer HospitalFirst Affiliated Hospital Xi'an Jiaotong University招聘中
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的